Welcome Guest user | Log in | Athens Login | Shibboleth Login | Register
Resources
Register
For Authors
For Librarians
For Advertisers
Services
Subscriptions/Pricing
Reprints
Advertising
Press Releases/News
Help
Downloads/Links
2008/9 Catalogue
Library Recommendation
 

Summary
Apr 2006, Vol. 7, No. 3, Pages 521-528 , DOI 10.2217/14622416.7.3.521
(doi:10.2217/14622416.7.3.521)

Collaborative Study: chronic fatigue syndrome – Perspective
Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary
Mark A Demitrack
Neuronetics, Inc., One Great Valley Parkway, Suite 2, Malvern, Pennsylvania 19355, USA.



Chronic fatigue syndrome (CFS) is a complex, multisymptom illness of unknown etiology. A variety of operational case definitions based on symptom report have been developed that share some common clinical features. Patients often come to clinical presentation after months or, more typically, years of symptomatic distress. Comorbid presentation with psychiatric illnesses has been noted. Due to these fundamental issues, the impact of patient selection and the specification of the methods of outcome assessment loom large in therapeutic studies of CFS. While a substantial body of research has focused on increasing our understanding of the basic pathobiology of CFS, there have been comparatively fewer studies that have addressed the problems of patient characterization and outcome assessment. The role of clinical methodology in the study of the therapeutics of CFS is not trivial, and may confound our understanding of pragmatic recommendations for treatment.

Full Text PDF (165 KB) PDF Plus (197 KB)
 

Prev. Article | Next Article
View/Print PDF (165 KB)
View PDF Plus (197 KB)
Add to favorites
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Author:
Mark A Demitrack
Keywords:
chronic fatigue syndrome
clinical trial methods
diagnosis
outcome assessment
therapeutics